GalactEXO®
Download Product Folder

Lyophilized enzyme for hydrolysis of β1-3,4-linked galactose

GalactEXO is a β-Galactosidase mix that hydrolyses β1-3,4-linked terminal galactose on N- and O-glycosylated proteins or oligosaccharides.
GalactEXO Lyophilized is available as a lyophilized powder in 2000 unit vials for hydrolysis of β1-3,4-linked galactose on 2 mg glycoprotein.
Lyophilized enzyme for hydrolysis of β1-3,4-linked galactose on 2 mg glycoprotein

For information on how to order, visit Place an Order or contact us directly at order@genovis.com.
One unit of GalactEXO Lyophilized hydrolyzes galactoses from >95% of 0.15 nmol Gal-β1,3-GalNAc-pNP and 2 nmol Gal-β1,4-GlcNAc-pNP when incubated in 20 mM Tris pH 6.8 at 37°C for 30 min. 1 unit of GalactEXO Lyophilized will hydrolyze the galactose of 1 μg of glycoprotein.
GalactEXO Lyophilized is reconstituted by addition of water. No preservatives added. After reconstitution, GalactEXO Lyophilized is stable for 1 month at +4-8°C. The product is shipped cold and should be stored at -20°C upon arrival.
Download Scientific Poster

Removal of glycan β-galactose to simplify IgG glycan heterogeneity, improve LC-MS analysis, and reveal underlying glycation modifications.
No. Branching fucose linked to the same residue as the β-galactose inhibits GalactEXO activity and needs to be removed prior to GalactEXO treatment. The FucosEXO enzyme can be used for hydrolysis of α1-2, α1-3 and α1-4 linked fucose.
Yes, you can. All three enzymes perform well in the same reaction buffer (20 mM Tris pH 6.8). There is no need to increase incubation time when combining the enzymes.
For most substrates such as antibodies or Fc-fusion proteins a 2 h incubation results in hydrolysis of over 95% of the present galactose. More complex substrates with high degree of galactosylation may require longer incubation times.
Yes, both beta1-3 linked galactose on O-glycans and beta1-4 galactose on N-glycans are hydrolyzed by GalactEXO.
All rights reserved. Genovis products may be covered by one or more patents, trademarks and copyrights owned by Genovis AB or licensed from third parties. For more information about commercial rights, please contact the Genovis team at licensing@genovis.com.
Genovis products are intended for research use only. They are not intended to be used for therapeutic or diagnostic purposes in humans or animals. All goods and services are sold subject to Genovis’ General Terms and Conditions of Sale.
© Genovis AB